ASN
CRL icon

Advisory Services Network’s Charles River Laboratories CRL Stock Holding History

Advisory Services Network’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$766K Buy
4,438
+386
+10% +$71.6K 0.01% 1056
2025
Q4 		$808K Buy
4,052
+826
+26% +$150K 0.01% 982
2025
Q3 		$505K Buy
3,226
+83
+3% +$13.2K 0.01% 1185
2025
Q2 		$533K Buy
3,143
+163
+5% +$21.7K 0.01% 1129
2025
Q1 		$449K Buy
2,980
+207
+7% +$34.7K 0.01% 1109
2024
Q4 		$512K Sell
2,773
-354
-11% -$68.2K 0.01% 1034
2024
Q3 		$646K Hold
3,127
– – 0.01% 880
2024
Q2 		$646K Sell
3,127
-278
-8% -$63K 0.01% 880
2024
Q1 		$923K Buy
3,405
+453
+15% +$108K 0.02% 717
2023
Q4 		$698K Sell
2,952
-89
-3% -$17.5K 0.02% 768
2023
Q3 		$596K Sell
3,041
-147
-5% -$30.2K 0.02% 833
2023
Q2 		$670K Buy
3,188
+2,840
+816% +$565K 0.02% 794
2023
Q1 		$70.2K Sell
348
-6
-2% -$1.36K ﹤0.01% 1836
2022
Q4 		$77.1K Buy
+354
New +$77.3K ﹤0.01% 1745
2022
Q2 		– Sell
-2,083
Closed -$592K – 1397
2022
Q1 		$592K Sell
2,083
-439
-17% -$135K 0.02% 843
2021
Q4 		$950K Sell
2,522
-429
-15% -$167K 0.03% 642
2021
Q3 		$1.22M Sell
2,951
-111
-4% -$46.1K 0.04% 529
2021
Q2 		$1.13M Sell
3,062
-55
-2% -$18.4K 0.04% 551
2021
Q1 		$903K Hold
3,117
– – 0.03% 584
2020
Q4 		$779K Sell
3,117
-549
-15% -$131K 0.03% 579
2020
Q3 		$829K Buy
3,666
+2,242
+157% +$465K 0.04% 458
2020
Q2 		$248K Sell
1,424
-135
-9% -$21.5K 0.01% 867
2020
Q1 		$197K Buy
1,559
+1,514
+3,364% +$227K 0.01% 825
2019
Q4 		$7K Sell
45
-91
-67% -$12.6K ﹤0.01% 2482
2019
Q3 		$19K Hold
136
– – ﹤0.01% 1841
2019
Q2 		$19K Buy
+136
New +$18.4K ﹤0.01% 1839
2019
Q1 		– Sell
-53
Closed -$6K – 2550
2018
Q4 		$6K Sell
53
-348
-87% -$43.6K ﹤0.01% 1953
2018
Q3 		$54K Buy
+401
New +$49.5K ﹤0.01% 1193

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Advisory Services Network's CRL Position: Q1 2026 in Review

Advisory Services Network increased its Charles River Laboratories (CRL) stake by 9.5% in Q1 2026, buying an estimated $71.6K and bringing the position to 4,438 shares worth $766K. The position accounts for 0.01% of the portfolio, ranked #1056.

Advisory Services Network first reported a position in CRL in Q3 2018 and has held it in 28 quarters since. The position peaked at $1.22M in Q3 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Advisory Services Network held 4,438 shares of Charles River Laboratories worth $766K as of Q1 2026.
  • Advisory Services Network bought 386 Charles River Laboratories shares in Q1 2026, an estimated $71.6K.
  • Charles River Laboratories made up 0.01% of Advisory Services Network's portfolio in Q1 2026, its #1056 holding.
  • Advisory Services Network first reported a position in Charles River Laboratories in Q3 2018 and has held it in 28 quarters since.
  • Advisory Services Network's Charles River Laboratories position peaked at $1.22M in Q3 2021.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.